Long-term outcome of breast conserving therapy

被引：11

作者：

Benson, John R. ^{[1
,2
]}

机构：

[1] Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England

[2] Univ Cambridge, Cambridge, England

来源：

LANCET ONCOLOGY | 2012年 / 13卷 / 04期

关键词：

20-YEAR FOLLOW-UP; MARGIN STATUS; MASTECTOMY; CANCER; SURGERY;

D O I：

10.1016/S1470-2045(12)70074-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：331 / 333

页数：4

共 13 条

[1]

Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0

[2]

Improving local control with breast-conserving therapy - A 27-year single-institution experience [J].

Cabioglu, N ;

Hunt, KK ;

Buchholz, TA ;

Mirza, N ;

Singletary, SE ;

Kuerer, HM ;

Babiera, GV ;

Ames, FC ;

Sahin, AA ;

Meric-Bernstam, F .

CANCER, 2005, 104 (01) :20-29

[3]

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].

Fisher, B ;

Anderson, S ;

Bryant, J ;

Margolese, RG ;

Deutsch, M ;

Fisher, ER ;

Jeong, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241

[4]

Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial [J].

Litiere, Saskia ;

Werutsky, Gustavo ;

Fentiman, Ian S. ;

Rutgers, Emiel ;

Christiaens, Marie-Rose ;

Van Limbergen, Erik ;

Baaijens, Margreet H. A. ;

Bogaerts, Jan ;

Bartelink, Harry .

LANCET ONCOLOGY, 2012, 13 (04) :412-419

[5]

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20 [J].

Mamounas, Eleftherios P. ;

Tang, Gong ;

Fisher, Bernard ;

Paik, Soonmyung ;

Shak, Steven ;

Costantino, Joseph P. ;

Watson, Drew ;

Geyer, Charles E., Jr. ;

Wickerham, D. Lawrence ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1677-1683

[6]

Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy [J].

Moore, MM ;

Borossa, G ;

Imbrie, JZ ;

Fechner, RE ;

Harvey, JA ;

Slingluff, CL ;

Adams, RB ;

Hanks, JB .

ANNALS OF SURGERY, 2000, 231 (06) :877-881

[7]

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence [J].

Park, CC ;

Mitsumori, M ;

Nixon, A ;

Recht, A ;

Connolly, J ;

Gelman, R ;

Silver, B ;

Hetelekidis, S ;

Abner, A ;

Harris, JR ;

Schnitt, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1668-1675

[8]

Current perceptions regarding surgical margin status after breast-conserving therapy - Results of a survey [J].

Taghian, A ;

Mohiuddin, M ;

Jagsi, R ;

Goldberg, S ;

Ceilley, E ;

Powell, S .

ANNALS OF SURGERY, 2005, 241 (04) :629-639

[9]

van Dongen J A, 1992, J Natl Cancer Inst Monogr, P15

[10]

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial [J].

van Dongen, JA ;

Voogd, AC ;

Fentiman, IS ;

Legrand, C ;

Sylvester, RJ ;

Tong, D ;

van der Schueren, E ;

Helle, PA ;

van Zijl, K ;

Bartelink, H .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (14) :1143-1150

← 1 2 →